About Daniel Lim

Daniel Lim is a partner in Kirkland & Ellis International LLP’s IP litigation practice in London, where he focuses on high-stakes life sciences patent litigation – particularly with regard to diagnostics, precision medicine, cell and gene therapy, and the pharmaceutical industry. His case experience includes oncology, molecular biology, diagnostics, antibody engineering and biostatistics, and often involves issues at the cutting edge of the law – notably in relation to second medical-use patents. He is active as a member of the International Association for the Protection of Intellectual Property (AIPPI) and the European Patent Lawyers Association (EPLAW), including as vice-chair of AIPPI’s standing committee on biotechnology.